Drugmakers and insurers could gain millions of customers under the legislation, but the industry also will pay new fees and
face stricter rules that may shrink profit and fuel mergers.
Beginning July 1, employees will be able to bring guns to work. A labor lawyer says employers will need to get creative.
Eli Lilly and Co. discovers, develops, manufactures and sells pharmaceutical products for humans and animals.
This is the wrong time, in my opinion, and I may not have all the facts, to open up Eli Lilly to an outside takeover.
The organization last year closed 11 business expansion or attraction deals, netting 2,950 new jobs in the process.
Netherlands-based Synthon Pharmaceuticals is seeking U.S. Food and Drug Administration approval to sell a copy of the medicine.
Companion Diagnostics Inc. moves from Connecticut to the IU Emerging Technologies Center, hopes to create 30 high-paying jobs
by 2014.
What would you do with $10 million? Indiana Health Information Technology Inc. wants to spend it to link
five medical records exchanges that operate separately around the state. The statewide organization received the money from
programs created by the federal stimulus bill. The group will link existing exchanges operated in and around Indianapolis,
Bloomington, Cincinnati, Fort Wayne and South Bend.
What’s this? A health insurance company trying to compete against Anthem Blue Cross and Blue Shield in central Indiana?
Consumer Life Insurance Co., a subsidiary of Medical Mutual of Ohio, has opened an office in Carmel with
intentions to sell group and individual policies. Consumers Life, which operates primarily in southern and northeastern Indiana,
has been expanding its network of doctors and hospitals in an attempt to reach statewide. The company has negotiated rates
with 44 hospitals and 5,000 physicians, and now employs 13 at its Carmel office, with plans to add more. It intends to extend
its SuperMed provider network statewide by the end of 2010.
Attaboy, here’s another contract. The Indiana State Department of Health awarded a $434,000 contract to the University
of Indianapolis Center for Aging & Community to lead an initiative to reduce infections acquired in health care
facilities. The new Indiana Healthcare Associated Infection Initiative will target such things as infections acquired from
catheters that aren’t completely sterile or from side effects of antibiotic use. The 15-month Indiana program will begin
in July and include at least 80 hospitals, nursing homes and home-health agencies. The latest initiative is modeled on the
Indiana Pressure Ulcer Prevention Initiative, which UIndy also oversees under a state contract. The first round of the pressure
ulcer initiative involved more than 160 hospitals, long-term care centers and home-health care providers and decreased the
incidence of pressure ulcers by 30 percent.
St. Francis Hospital & Health Centers has acquired a six-doctor orthopedic surgery practice that operates
in St. Francis’ Mooresville hospital. Joint Replacement Surgeons of Indiana fully integrated with St.
Francis on Monday, the hospital system announced. The physician group will be called St. Francis Medical Group-Joint Replacement
Surgeons. The doctors will continue working out of the St. Francis-Mooresville campus and the St. Vincent Indianapolis
Hospital campus on West 86th Street.
Eli Lilly and Co. paid $50 million for exclusive rights from Acrux Ltd. to an underarm testosterone lotion
called Axiron for men with limited sex drive due to low levels of the hormone, according to Bloomberg News. Indianapolis-based
Lilly will also pay Acrux, based in West Melbourne, Australia, $3 million when manufacturing assets are transferred. Acrux
may earn $87 million more if U.S. regulators approve the drug for sale, an additional $195 million in commercial milestone
payments, and royalty payments on future sales.
Clarian Health is expanding its LifeLine Critical Care Transport service to Lafayette and Muncie, making
its Clarian Arnett and Ball Memorial Hospital into regional centers for critical care. When the new cities come online in
July, LifeLine will operate from six bases. Its other locations are in Indianapolis, Columbus, Kokomo and Terre Haute. Each
LifeLine team includes a pilot, nurse, and a flight paramedic or respiratory therapist, depending on the needs of the patient
being transported. LifeLine conducts more than 1,500 flights annually.
Indianapolis-based Nyhart Co. has acquired ASAP Flex Plans, a 7-year-old firm that helps
smaller employers administer employee flexible spending accounts, health savings accounts, health reimbursement accounts and
COBRA benefits. ASAP owner John Baird will join Nyhart as a consultant, spearheading a rollout of new flexible spending accounts
by year’s end. ASAP’s 150 clients will be served under the Nyhart name.
Indiana health-related companies were somewhat absent from the lobbying bonanza that gripped Washington, D.C., in 2009. For
all the heat and light about health reform, major Indiana companies actually spent slightly less to lobby Congress.
Pharmaceuticals stolen Sunday morning could be worth up to $75 million.
Eli Lilly & Co., the maker of the impotence pill Cialis, bought exclusive rights from Australia’s Acrux Ltd. to
an underarm testosterone lotion called Axiron for men with limited sex drive due to low levels of the hormone.
Indianapolis-based Lilly will pay Acrux of West Melbourne, Australia, a $50 million license fee, plus $3 million when manufacturing
assets are transferred, but the deal could be worth millions more.
Regulators won’t require more time-consuming tests of the drug, but want Eli Lilly and Co. and its partners to clarify labeling,
manufacturing
processes.
With President Obama looking to squeeze a bit more revenue out of the pharmaceutical industry, the stakes just keep getting higher for Eli Lilly and Co.’s efforts to develop drugs faster and cheaper. Lilly is already trying to shave a year or more off the time it takes the company’s scientists to turn a newly […]
Two of the five most-advertised drugs belong to hometown drugmaker Eli Lilly and Co. According to 2009 data from The Nielsen Co., Lilly spent $178 million to advertise Cymbalta, its antidepressant and pain medicine, and another $167 million to hawk Cialis, its anti-impotence pills. Those two drugs ranked No. 4 and No. 5, respectively. They […]
The acquisition will benefit Elanco, Lilly’s animal health division in Greenfield, which has become increasingly important
to Lilly as it braces for patent-protection losses.
Brightpoint, WellPoint and Cummins are recognized by Fortune magazine as being among the best in their industries.
Lilly Endowment’s resistance to diversify its holdings reached a new height last year, as it failed to sell a single share
of the underperforming Eli Lilly and Co. stock while the broader market surged.
